• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dental surgery in patients with severe factor XI deficiency without plasma replacement.

作者信息

Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U

机构信息

Institute of Hematology, Tel Aviv-Sourasky Medical Center, Israel.

出版信息

Blood Coagul Fibrinolysis. 1992 Aug;3(4):465-8.

PMID:1420822
Abstract

Bleeding following dental extraction is frequently the first manifestation of severe factor XI deficiency. Safe oral surgery has previously been performed in such patients by using plasma replacement therapy with or without concomitant administration of antifibrinolytic agents. The aim of this study was to determine whether such patients can undergo safe dental extractions using only an antifibrinolytic agent. The study group consisted of 19 patients with severe factor XI deficiency (factor XI:C level less than 14 U/dl) who had previously bled following dental extractions (14 patients) or other trauma (five patients). Tranexamic acid, 1 g q.i.d., was given from 12 h before surgery, until 7 days afterwards. No excessive bleeding was observed following dental extractions. One patient had slight oozing after 3 days which ceased spontaneously. Thus, plasma replacement no longer appears necessary for patients with severe factor XI deficiency requiring dental extractions.

摘要

相似文献

1
Dental surgery in patients with severe factor XI deficiency without plasma replacement.
Blood Coagul Fibrinolysis. 1992 Aug;3(4):465-8.
2
Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.重组活化凝血因子VII和氨甲环酸在患有抑制性抗体的XI因子缺乏患者的大手术期间具有止血效果。
Thromb Haemost. 2009 Sep;102(3):487-92. doi: 10.1160/TH09-03-0172.
3
Tranexamic acid mouthwash--a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions.氨甲环酸漱口水——一项前瞻性随机研究,比较2天疗程与5天疗程用于预防需要拔牙的抗凝患者术后出血的效果。
Int J Oral Maxillofac Surg. 2003 Oct;32(5):504-7.
4
Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects.围手术期改良血栓弹力图在因子XI缺乏症中的应用:一种评估药物效果的有用方法。
Acta Anaesthesiol Scand. 2007 May;51(5):640-3. doi: 10.1111/j.1399-6576.2007.01284.x.
5
Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study.XI因子缺乏家族中出血倾向的定义——一项临床与实验室研究
Thromb Haemost. 1995 Feb;73(2):194-202.
6
Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy.不同类型的手术在严重因子 XI 缺乏症患者中表现出不同的出血症状,这使得替代疗法的使用更加精简。
Haemophilia. 2006 Sep;12(5):490-3. doi: 10.1111/j.1365-2516.2006.01304.x.
7
Cataract extraction without prophylactic treatment in patients with severe factor XI deficiency.严重因子XI缺乏症患者未进行预防性治疗的白内障摘除术。
Am J Ophthalmol. 2009 Dec;148(6):920-4.e1. doi: 10.1016/j.ajo.2009.07.013. Epub 2009 Sep 5.
8
[Mouth-washing with tranexamic acid in patients treated with oral anticoagulants subjected to oral surgery procedures].[接受口腔外科手术的口服抗凝剂治疗患者使用氨甲环酸漱口]
Invest Clin. 1998 Jun;39(2):77-83.
9
Effectiveness in controlling haemorrhage after dental scaling in people with haemophilia by using tranexamic acid mouthwash.使用氨甲环酸漱口水对血友病患者洗牙后出血的控制效果。
Br Dent J. 2005 Jan 8;198(1):33-8; discussion 26. doi: 10.1038/sj.bdj.4811955.
10
The obstetric experience of women with factor XI deficiency.患有因子 XI 缺乏症女性的产科经历。
Acta Obstet Gynecol Scand. 2009;88(10):1095-100. doi: 10.1080/00016340903144238.

引用本文的文献

1
Congenital factor XI deficiency with multiple tooth extractions (Case report).先天性因子XI缺乏症伴多颗牙齿拔除(病例报告)
Exp Ther Med. 2023 Sep 15;26(5):509. doi: 10.3892/etm.2023.12208. eCollection 2023 Nov.
2
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.部分因子 XI 缺乏症患者的血浆异常凝结形成和纤维蛋白溶解揭示了出血倾向。
Blood Adv. 2018 May 22;2(10):1076-1088. doi: 10.1182/bloodadvances.2017015123.
3
Factor XI deficiency and orthognathic surgery: a case report on anesthesia management.
因子 XI 缺乏症与正颌外科手术:一例麻醉管理病例报告
J Dent Anesth Pain Med. 2015 Mar;15(1):25-29. doi: 10.17245/jdapm.2015.15.1.25. Epub 2015 Mar 31.
4
Why factor XI deficiency is a clinical concern.为什么因子 XI 缺乏症是一个临床关注点。
Expert Rev Hematol. 2016 Jul;9(7):629-37. doi: 10.1080/17474086.2016.1191944. Epub 2016 Jun 24.
5
Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.在常规临床实践中使用凝血因子 XI 替代治疗遗传性凝血因子 XI 缺乏症:HEMOLEVEN 前瞻性 3 年上市后研究结果
Haemophilia. 2015 Jul;21(4):481-9. doi: 10.1111/hae.12655. Epub 2015 Mar 26.
6
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.意大利血友病及先天性出血性疾病的治疗原则与管理建议更新
Blood Transfus. 2014 Oct;12(4):575-98. doi: 10.2450/2014.0223-14.
7
Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.异常的血浆凝块结构和稳定性可区分重度因子XI缺乏症患者的出血风险。
J Thromb Haemost. 2014 Jul;12(7):1121-30. doi: 10.1111/jth.12600. Epub 2014 Jun 19.
8
Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.临床实践:出血患儿。第二部分:继发性止血和纤维蛋白溶解紊乱。
Eur J Pediatr. 2012 Feb;171(2):207-14. doi: 10.1007/s00431-011-1571-x. Epub 2011 Sep 17.
9
Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.罕见遗传性凝血障碍患者出血发作的预防及外科干预
Blood Transfus. 2008 Sep;6 Suppl 2(Suppl 2):s39-44. doi: 10.2450/2008.0036-08.
10
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.通过中和因子XI增强兔颈静脉溶栓作用。因子XI作为抗纤溶因子作用的体内证据。
J Clin Invest. 1998 Jan 1;101(1):10-4. doi: 10.1172/JCI781.